文献速递骨肌US

重新审视黏性补充疗法:超声引导与体表标志引导注射治疗膝骨关节炎的比较

Rethinking Viscosupplementation: Ultrasound- Versus Landmark-Guided Injection for Knee Osteoarthritis.
PubMed 文献 · J Ultrasound Med · 2019-06-25

该研究分析了1147例接受膝部透明质酸注射的社区居住患者,比较超声引导(n=500)与体表标志引导(n=647)注射后的无手术生存率。超声引导组后续接受膝关节置换术的比例为33.2%,显著低于体表标志引导组的45.8%(P < .001);肥胖患者亚组中差异更大(34.8% vs 51.8%,P < .001)。结论认为超声引导确保关节内针尖放置可优化黏性补充疗法的疗效。

要点

  • 超声引导膝部透明质酸注射后行膝关节置换的比例为33.2%,低于体表标志引导的45.8%(P < .001)。
  • 肥胖患者亚组中超声引导组手术比例为34.8%,体表标志引导组为51.8%(P < .001)。
  • 体表标志引导注射在肥胖患者中准确性可能较差,超声引导可确保关节内针尖放置。

核心结论

  • 超声引导膝部透明质酸注射的患者后续接受膝关节置换术的可能性显著低于体表标志引导注射的患者,重新审视黏性补充疗法以确保关节内递送可提高有效性。

研究设计与样本

  • 分析6个相邻县所有接受膝部透明质酸注射的社区居住患者,体表标志引导组n=647,超声引导组n=500,比较关节炎程度、体重指数、后续注射及是否需要膝关节置换术,并对肥胖患者进行亚组分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Viscosupplementation, intra-articular injection of hyaluronic acid (HA), for knee osteoarthritis has fallen somewhat out of favor, with studies failing to show consistent benefits in pain reduction. Hyaluronic acid must enter the joint space to be beneficial; however, landmark-guided injection can be substantially inaccurate, especially in obese patients. We aimed to determine whether ultrasound (US) guidance to ensure needle placement for HA knee injection resulted in improved outcomes as reflected by surgery-free survival compared to landmark-guided HA knee injection.

METHODS: All community-dwelling patients in 6 contiguous surrounding counties receiving HA knee injection either by landmark guidance (n = 647) or by US guidance (n = 500) were analyzed for the degree of arthritis, body mass index, follow-up injection, and subsequent need for knee arthroplasty. A subgroup analysis of obese patients was also performed.

RESULTS: The US- and landmark-guided HA injection cohorts were similar with respect to sex, body mass index, and the degree of arthritis. Of 1147 patients receiving knee HA injection, 462 subsequently underwent knee arthroplasty. Significantly fewer patients in the US-guided HA injection cohort went to surgery (33.2%) compared to the landmark-guided cohort (45.8%; P < .001). The subgroup analysis for obese patients showed even larger differences (34.8% versus 51.8%; P < .001).

CONCLUSIONS: Knee osteoarthritis treatment by viscosupplementation can be optimized by US guidance, ensuring intra-articular needle placement. Using an objective surgical outcome, our study shows that rethinking viscosupplementation to ensure intra-articular delivery improves effectiveness. Patients receiving US-guided knee HA injection were significantly less likely to undergo subsequent knee arthroplasty than patients receiving landmark-guided HA injection.

来源:J Ultrasound Med,查看原文。版权归原作者所有。

引用

  1. Lundstrom ZT, Sytsma TT, Greenlund LS, et al. Rethinking Viscosupplementation: Ultrasound- Versus Landmark-Guided Injection for Knee Osteoarthritis. J Ultrasound Med. 2019. PMID: 31237389. doi:10.1002/jum.15081

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。